Your input is needed! Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, is seeking your opinion on the current state of pharmacy, and where it’s headed...
Here are some of the innovative approaches payers and providers are taking to quell the diabetes epidemic, and curb the costs associated with it.
Concerns among stakeholders may call for EHR system revamping
An in-depth look at the effects of PDMPs, which are electronic databases used to track the prescribing and dispensing of controlled prescription drugs to patients.
While value-based reimbursement presents opportunities for payers and providers, succeeding in such a reimbursement model can be challenging. Here are four things to strive for that could increase the likelihood of success in a value-...
Model set to improve compliance, reduce costs, but reimbursement challenges remain.
Factors include rising costs of brand medications, increased specialty therapy use
Shared resources, specialized drugs key to curbing costs
Considering entering into a risk-sharing agreement with another payer or provider? Avoid these top mistakes.
PBMs, insurers use cautious approach when managing these cholesterol-lowering drugs.